Effects of Long-term Remote Ischemic Preconditioning on Clinical Outcome in Patients With Acute Myocardial Infarction

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

At present, there are 290 million cardiovascular patients in China, including 11 million patients with coronary heart disease. Remote ischemic preconditioning(RIPC) may play an effective endogenous cardiac protection.This study will explore whether long-term use of RIPC in patients with AMI after PCI and non interventional therapy can reduce the incidence of major adverse cardiovascular cerebrovascular events(MACCE) and improve clinical outcomes and long-term prognosis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with acute myocardial infarction were diagnosed in accordance with the criteria of the Global Unified Definition of Fourth Myocardial Infarction

Locations
Other Locations
China
Fuwai Central China Cardiovascular Hospital
RECRUITING
Zhengzhou
Contact Information
Primary
Muwei LI
lmw0207@163.com
13838083966
Backup
GUO QUAN
xinyiguoquan@163.com
15670510031
Time Frame
Start Date: 2025-01-01
Estimated Completion Date: 2028-12-01
Participants
Target number of participants: 2146
Treatments
Experimental: Experimental Group1(RIPerC+RIPC)
Remote ischemic PERconditioning was initiated immediately after the diagnosis of acute myocardial infarction, and Remote ischemic PREconditioning was performed daily after discharge
Experimental: Experimental Group2(RIPerC)
Remote ischemic PERconditioning was initiated immediately after the diagnosis of acute myocardial infarction
No_intervention: Control group
A group of patients who received conventional treatment without any additional intervention
Related Therapeutic Areas
Sponsors
Leads: Henan Institute of Cardiovascular Epidemiology

This content was sourced from clinicaltrials.gov

Similar Clinical Trials